News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Markets await Services PMI, ISM Non‑Manufacturing PMI and Fed Governor Waller remarks, with CFTC reports and Treasury bill auctions adding short‑term funding signals.
  • Russian cross‑regional strikes killed six civilians and injured dozens, raising fresh geopolitical risk after attacks near Zaporizhzhia nuclear plant.
  • Peru's electoral office confirmed Keiko Fujimori's narrow victory, triggering protests and continued political uncertainty that could affect investor sentiment.
  • Chery Auto assumed the Rosslyn plant, pledged millions in upgrades, retained 692 employees, and plans mid‑2027 vehicle production and local job creation.
  • REE Automotive received a Nasdaq delisting notice, with Class A shares set to be suspended July 7 for failing minimum bid price rules.
  • Ferrari unveiled the 12Cilindri Manuale, a 1,499‑unit V12 manual grand tourer priced from €590,000, targeting collector demand.

Latest Articles

VCI Global Strengthens Capital Alignment Following Premium Warrant Conversion by Institutional Investor

VCI Global Strengthens Capital Alignment Following Premium Warrant Conversion by Institutional Investor

VCI Global Limited announces that Esousa Group Holdings LLC, a New York-based institutional investor, converted warrants into 880,000 shares of common stock at a 24.9% premium to the previous closing price. This conversion underscores institutional confidence in VCI Global's AI-native platform strategy and strengthens the company's equity capital s…

Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management

Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management

Vivani Medical has obtained regulatory approval from an Australian human research ethics committee to initiate its Phase 1 clinical trial, SLIM-1, testing the NPM-139 semaglutide implant designed for obesity and chronic weight management. This implant aims to improve medication adherence by providing a steady drug delivery over an extended period. …

KUSTOM ENTERTAINMENT, INC. ANNOUNCES BINDING AGREEMENT FOR THE DIVESTITURE OF ITS VIDEO SOLUTIONS SEGMENT TO FULLY COMPLETE LIVE ENTERTAINMENT PIVOT

KUSTOM ENTERTAINMENT, INC. ANNOUNCES BINDING AGREEMENT FOR THE DIVESTITURE OF ITS VIDEO SOLUTIONS SEGMENT TO FULLY COMPLETE LIVE ENTERTAINMENT PIVOT

Kustom Entertainment, Inc. announces a binding agreement to divest its video solutions segment to Cycurion, Inc. The transaction includes $5.5 million plus 2 million warrants, enabling Kustom to focus on its growing live event production and ticketing business. This aligns with its recent rebranding and partnership with Gilley's Park City, position…

Prairie Operating Co. Appoints Gregory S. Patton Chief Executive Officer and Director and Michael J. Shelly Chief Financial Officer

Prairie Operating Co. Appoints Gregory S. Patton Chief Executive Officer and Director and Michael J. Shelly Chief Financial Officer

Prairie Operating Co., a Nasdaq-listed independent energy company focused on oil and natural gas development in the Denver-Julesburg Basin, announced key leadership changes with Gregory S. Patton appointed as CEO and Michael J. Shelly as CFO. These appointments aim to support the company's next growth phase, optimize capital structure, and enhance …

Plus Therapeutics Secures National Coverage Agreement with Elevance Health for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer

Plus Therapeutics Secures National Coverage Agreement with Elevance Health for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer

Plus Therapeutics' subsidiary CNSide Diagnostics has signed a national coverage agreement with Elevance Health to provide the CNSide® Cerebrospinal Fluid Tumor Cell Enumeration assay, expanding coverage to approximately 126 million people in the U.S. The CNSide® assay aids rapid diagnosis and treatment monitoring for patients with leptomeningeal me…

OptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning Platforms

OptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning Platforms

OptimizeRx Corp. announced the launch of its patent-pending Natural Language Audience Builder (NLAB), an AI-driven tool designed for integration within demand-side platforms (DSPs) and agency media planning platforms. NLAB allows life sciences marketers to build and refine custom healthcare provider audiences using real-world evidence and proprieta…

Susquehanna Boosts Micron Price Target to $2,000 After Blowout Quarter

Susquehanna Boosts Micron Price Target to $2,000 After Blowout Quarter

Susquehanna raised its Micron Technology price target to $2,000 from $1,750 after the memory chipmaker delivered record fiscal third-quarter results and guidance that exceeded analyst estimates. The upgrade follows a string of long-term, non-cancellable customer agreements that cover significant portions of DRAM and NAND supply and include price fl…

NuCube Energy to Become a Publicly Listed Company Through Business Combination with Launch Two Acquisition Corp.

NuCube Energy to Become a Publicly Listed Company Through Business Combination with Launch Two Acquisition Corp.

NuCube Energy, an advanced nuclear technology firm developing solid-state microreactors, has agreed to a business combination with Launch Two Acquisition Corp. (NASDAQ: LPBB), bringing NuCube to the public markets with an estimated valuation of $500 million pre-money. NuCube's NuSun™ microreactor technology delivers firm carbon-free power and high-…

High-Immigrant Nations See Large Productivity and Investment Gains, Study Finds

High-Immigrant Nations See Large Productivity and Investment Gains, Study Finds

A new study examining immigration trends across wealthy OECD countries finds that higher inflows over the past 35 years are strongly associated with faster growth in GDP per worker and increased investment. The paper reports that an inflow equal to 1% of population correlates with a 1.2% rise in productivity within five years and 1.9% within ten ye…

Microsoft Pullback: Tactical Long on an Overdone Dip

Microsoft Pullback: Tactical Long on an Overdone Dip

Microsoft's share price has pulled back to $365.45 on heavy volume, testing levels near the 52-week low after headlines and momentum selling. Fundamentals - $2.71T market cap, $72.9B free cash flow, 30% ROE, and a manageable debt load - remain intact. This trade idea targets a rebound to $395 with a stop at $352 on a mid-term (45 trading days) hori…

BlackBerry Raises 2027 Revenue Outlook as QNX Drives First-Quarter Strength

BlackBerry Raises 2027 Revenue Outlook as QNX Drives First-Quarter Strength

BlackBerry lifted its full-year 2027 revenue forecast after reporting a strong first quarter driven by its QNX division, which supplies secure operating systems for automotive and other embedded systems. QNX revenue climbed nearly 26% to $72.3 million for the quarter ended May 31 and carries a backlog of almost $1 billion in future royalties. The c…

Digital Currency X Technology Enters Into Securities Purchase Agreement for a Private Placement of US$700 Million of Units, Payable in U.S. Dollars or Digital Assets, to Advance Its Digital Asset Treasury Strategy

Digital Currency X Technology Enters Into Securities Purchase Agreement for a Private Placement of US$700 Million of Units, Payable in U.S. Dollars or Digital Assets, to Advance Its Digital Asset Treasury Strategy

Digital Currency X Technology Inc. announced a $700 million private placement of units payable in U.S. dollars or digital assets, marking a strategic shift from electric vehicle manufacturing to focus on digital asset treasury management and AI cloud computing services. The financing structure aligns with its digital asset holdings, allowing direct…

WidePoint Jumps After Landing $3.1 Billion DHS Wireless Services Contract

WidePoint Jumps After Landing $3.1 Billion DHS Wireless Services Contract

WidePoint Corporation's stock climbed sharply after the company was named the sole awardee for the Department of Homeland Security's Cellular Wireless Managed Services 3.0 contract, a 10-year IDIQ with a contract ceiling of roughly $3.1 billion and an ordering period beginning June 25, 2026. The award tasks WidePoint with providing an integrated su…

Citizens Financial Services Insider Activity and Governance Updates: LeeAnn Gephart's Recent Sale and New Board Appointment

Citizens Financial Services Insider Activity and Governance Updates: LeeAnn Gephart's Recent Sale and New Board Appointment

LeeAnn Gephart, Executive Vice President at Citizens Financial Services Inc (NASDAQ: CZFS), executed a share sale on June 25, 2026, disposing of 29 shares at $66.52 per share. The transaction resulted in a total value of $1,929. Post-transaction, Gephart retains direct ownership of 808 shares of the company's common stock. This insider activity occ…

Researchers Say Simpler Bank Rules Could Create Evasion Pathways

Researchers Say Simpler Bank Rules Could Create Evasion Pathways

A new research paper to be shown at the European Central Bank's Sintra conference next week argues that reducing the complexity of bank regulation can unintentionally weaken the system by making rules easier to circumvent. The study, which includes work from Stockholm School of Economics professor Mariassunta Giannetti, finds that simpler rules are…

NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Treats First Patients Using Zeta Surgical's FDA-Cleared Zeta TMS Navigation System

NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Treats First Patients Using Zeta Surgical's FDA-Cleared Zeta TMS Navigation System

NRx Pharmaceuticals' subsidiary HOPE Therapeutics has initiated treatment of the first patients using Zeta Surgical's FDA-cleared Zeta TMS Navigation System at its Florida clinics. This milestone represents a shift from research to active clinical application, enabling AI-driven precise targeting in transcranial magnetic stimulation (TMS) therapies…